Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Buccal Naloxone
NCT02733822Phase 1Unknown
- Sponsor
- King's College London
- Start
- Jun 2016
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of naloxone in opioid overdose (4 arms), sponsored by King's College London. Primary endpoint: Time to Peak Concentration at 8 hours. Status: unknown.
02
Drugs
naloxone
03
Conditions
opioid overdose
Beyond the preview
Go deeper on NCT02733822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02733822.